---
$id: https://graph.org.ai/products/commodity/51181929
$type: Product
source: UNSPSC
code: "51181929"
title: "Ganirelix acetate"
class: "51181900"
classTitle: "Gonadotropic hormones and ovarian stimulants and inhibitors"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ganirelix acetate

**UNSPSC Code**: 51181929
**Class**: [Gonadotropic hormones and ovarian stimulants and inhibitors](Gonadotropic hormones and ovarian stimulants and inhibitors.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a gonadotropin releasing hormone inhibitor with the molecular formula C80H113CLN18O13.2C2H4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 56U7906FQW. European Medicines Agency schedules ganirelix acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25637. The term ganirelix acetate is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule ganirelix acetate under HS 29371900 and SITC 54154. Ganirelix acetate bears US NLM identifiers UMLS ID C0872894 and NCI Concept Code C61774. SMILES: As of Q4 2014, GANIRELIX ACETATE remains US FDA's Preferred Term for this commodity.

